BCMA and SLAMF7 chimeric antigen receptors T-cells immunotherapy in multiple myeloma

Project title: BCMA and SLAMF7 chimeric antigen receptors T-cells immunotherapy in multiple myeloma (BITRECS)

Funding agency: European Union

Start and end date: 01/10/2019- 01/10/2021